Source: Annual Congress 2012 - Infection control of respiratory pathogens
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Nicoll (Stockholm, Sweden). Influenza viruses: risks and prevention of their transmission. Annual Congress 2012 - Infection control of respiratory pathogens

Member's Comments

No comment yet.

Related content which might interest you: Impact of the COVID-19 pandemic on Influenza virus transmission Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021 Avian influenza and SARS – how much of a threat is it to humans and what can be done to prevent this? Source: Annual Congress 2005 - Major viral threats to the lung Year: 2005 Assessing the potential pandemic risk of recent avian influenza viruses Source: Eur Respir J , 49 (3) 1602517; DOI: 10.1183/13993003.02517-2016 Year: 2017 Risk factors of fatal outcomes in influenza A/H1N1-09 viral infection Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic Year: 2011 Preventing the next influenza pandemic Source: International Congress 2015 – PG11 Emerging infectious diseases and pandemic planning Year: 2015 Influenza: from zoonosis to pandemic Source: ERJ Open Res 2016 Year: 2016 Influenza A/H1N1v infection in Belgian children with and without underlying risk factor Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010 Prevention and treatment of viral infections: CMV and other community respiratory viruses Source: ERS Course 2016 Year: 2016 Influenza vaccination: protecting the most vulnerable Source: Eur Respir Rev, 30 (159) 200258; 10.1183/16000617.0258-2020 Year: 2021 Epidemic and pandemic viral infections: impact on tuberculosis and the lung Source: Eur Respir J, 56 (4) 2001727; 10.1183/13993003.01727-2020 Year: 2020 The relation of people to vaccination against an influenza virus Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Clinical and epidemiological features in H1N1 and H3N2 influenza A virus Source: International Congress 2015 – Viral infections: basic research and clinical perspective Year: 2015 Influenza surveillance and vaccination: new developments Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice Year: 2017 Obesity as the most considerable risk factor for death due to influenza A/H1N1-09 viral infection Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Early diagnosis and causal treatment of pneumonia associated with pandemic influenza A (H1N1) virus Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Palivizumab: Is it cost effective to extend the vaccination period for patients at risk of severe respiratory syncytial virus infection? Source: Virtual Congress 2021 – Acute and chronic lung infections in children Year: 2021 The spread of influenza viruses. State of the pandemic and prediction Source: Annual Congress 2009 - The influenza A (H1N1) pandemic Year: 2009 How contagious are the new viruses and how can you protect yourself? Source: Annual Congress 2005 - Major viral threats to the lung Year: 2005 Influenza vaccination in children with high-risk chronic diseases Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021 Widespread use of face masks and respiratory viral infections: the SARS-CoV-2 pandemic lesson Source: Virtual Congress 2021 – Acute and chronic lung infections in children Year: 2021